About Us

WHAT IS TELARA PHARMA

Telara Pharma is a global leader in repurposing the drug cilastatin to make new therapies for severe inflammatory disorders like Acute Kidney Injury (AKI).

The scientific team of TELARA has spent years studying toxic and non-toxic aggressions suffered by the kidneys with the aim of preventing and treating AKI. The company arises out of the pioneering work on nephroprotection carried out with cilastatin by the team of the KOL Dr. Alberto Tejedor to cover a medical need that is not currently addressed.

WHAT WE DO WE DO BEST

We are currently advancing cilastatin into phase II clinical trials for the treatment of AKI induced by toxics, sepsis, and sepsis-included acute kidney failure and moving forward proprietary programs to clinical trials to repurpose cilastatin for neuroinflammatory disorders.

OUR VISION

Our vision is to contribute to the identification of new therapeutic tools for the prevention and treatment of acute renal failure and sepsis, and to reduce mortality rates that have remained unchanged for more than 50 years.

OUR VALUES

We are guided by values of professionalism, responsibility, honesty, tenacity, perseverance, efficiency, respect, and sensitivity.

OUR MISSION

Telara pharma's mission is to bring to clinical use the first kidney-protective drug to prevent and treat sepsis and septic and toxic acute renal failure, improve patients' quality of life, reduce their hospital stay and help save lives.

Our TEAM

Teresa Tarragó, PhD, MBA

Chief Executive Officer

Alberto Lázaro, PhD

Founder & Chief Scientific Officer

Amparo Bravo, PhD, MD

Founder & Chief Medical Officer

Elena Vázquez, PhD

Researcher

Our ADVISORS

GENESIS Biomed

A consulting company specialised in R + D + i projects in the biomedical sector (www.genesis-biomed.com). GENESIS supported Gregorio Marañón Hospital Health Research Institute for the creation of Telara Pharma, and essentially, it deals with fundraising and business development.

Josep Lluís Falcó

Founder and CEO

Doctor in Chemistry (Institut Químic de Sarrià, 2001) and MBA (UB, 2007).

View profile

Jordi Ortiz

Senior Consultant

MSc in Chemistry, Biochemistry field (Universitat de Barcelona).

View profile

IN MEMORIAM

Dr. Alberto Tejedor Jorge (1957-2020)

Dr. Alberto Tejedor Jorge (1957-2020) was a Professor of Nephrology and Vicedean at Complutense University of Madrid, Head of the Acute Interconsultation Unit in Acute Renal Failure of the Nephrology Department of the Gregorio Maranon Universitary General Hospital of Madrid, and Principal Investigator of the Renal Pathophysiology Lab in the Gregorio Maranon Health Research Institute, Madrid, Spain.

He obtained his M.D. and Ph.D. at Autonoma University of Madrid and he was Fellow of Nephrology at University of Texas Southwestern Medical Center, Dallas. He trained with Dr. Alberto Sols (Madrid) in metabolism control and regulation; with Dr. Hernando (Madrid) in general nephrology; with Dr. Vinay (Groupe de Transport membranaire, University of Montreal) in renal transport energetics; with Dr. Moshe Levy (Veterans Administration Hospital, Dallas) in phospho-calcium renal metabolism and with Dr. Alpern (Parkland Hospital, Renal Division, Health Science Center, Dallas) in H + transport regulation. Alberto Tejedor was the discoverer of cilastatin as a kidney protector, has published over 150-peer-reviewed publications and book chapters, and has been awarded by the Spanish Society of Nephrology in 1994 and 1996, the University of Alcala de Henares in 2014, Alcer Renal Foundation in 2017 and Complutense University of Madrid in 2018 for his research. He was also co-founder of the European Hyponatremia Network.

Over the last 30 years, he has led and mentored graduate students and postdoctoral fellows now working for prestigious international research companies and institutes. He was always generous and didactic with all of them, and insatiable in his struggle for the advancement of knowledge.

His work as a teacher has been recognized by his students and colleagues, in which he was always involved in his efforts to transmit his love for medicine and the imperative need to heal, care for and accompany the sick.